Industries > Pharma > Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024

Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024

Prospects For Leading Players

PUBLISHED: 11 March 2014
PAGES: 205
PRODUCT CODE:
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: N/A Categories: ,

Vaccine manufacturing technology and services – your guide to trends and revenue prospects for vaccine production

What's the outlook for producing vaccines? Visiongain's brand new report shows you the potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our 205 page report provides 104 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market, submarket and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions.

There's rising demand for those products and services. In particular, outsourced vaccine manufacturing will expand from 2014 to 2024, with growing revenues.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of four exclusive expert opinion interviews from an industry specialist informing your understanding and allowing you to assess prospects for investments and sales:
– Dr. Eluemuno Blyden, CEO and Founder, AfriVax
– Chris Redmond, GMP and nonGMP Sales Manager, Ambiopharm
– Dr. Victor Van Cleave, Vice President of Contract Manufacturing & Research and Development (R&D), Meridian Life Science
– Dr. Stefan Beyer, Managing Director, Vibalogics

You will find prospects for key submarkets

In addition to analyses of the overall world market, you will see revenue forecasting for these five world-level vaccine submarkets to 2024:
–    Paediatric vaccines
–    Influenza vaccines
–    Adult prophylactic vaccines
–    Therapeutic vaccines
–    Contract vaccine manufacturing

Our investigation shows business research and analysis with individual revenue forecasts and discussions. Which vaccine submarket will generate the most revenues? How will the vaccine contract manufacturing market expand? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.

What are the prospects for vaccine contract manufacturing in the leading regions and countries?

Events and progress worldwide will influence the market, especially outsourced vaccine manufacturing in emerging countries.

In our study you will find individual revenue forecasts to 2024 for 11 vaccine contract manufacturing national markets:
–    US
–    Japan
–    Germany
–    Italy
–    Spain
–    France
–    UK
–    Russia
–    China
–    India
–    Brazil
–    RoW

Many opportunities exist within the vaccines contract manufacturing market. Greater uptake of existing technology and products worldwide will also stimulate the industry and market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints. See what is likely to achieve the most success.

Leading companies and potential for market growth

Overall world revenue for the vaccines contract manufacturing market will reach $705.62m in 2014, our study forecasts. We predict strong revenue growth from 2014 to 2024. Our research shows you what organisations hold greatest potential. See profiles of 10 leading companies, including these:
–    Baxter BioPharma Solutions
–    Boehringer Ingelheim
–    Catalent
–    Charles River Laboratories
–    IDT Biologika GmbH
–    Lonza
–    Meridian Life Science
–    Sigma-Aldrich
–    SynCo Bio Partners
–    OSO BioPharmaceuticals Manufacturing

In general, a company profile gives you the following information:
–    Overview of the company
–    Discussion of a company's activities and outlook including descriptions of leading products
–    Recent financial results
–    Assessment of recent developments – mergers and acquisitions (M&A),  new products, and collaborations, inc. alliances, partnerships and joint ventures

What issues will affect the vaccine contract manufacturing market?

Our new report discusses issues and events affecting the vaccine contract manufacturing market. You will find discussions, including qualitative analyses:
–    Healthy pipeline of vaccine products
–    Cell-based techniques – mammalian cell lines, avian-derived cells, plant-based processes and other methods
–    Pandemic preparedness
–    Pricing, regulation and government policy
–    Perception of risk in outsourcing vaccine manufacturing

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024: Prospects For Leading Players report helps you

In summary, our 205 page report gives you the following knowledge:
–    Revenues forecasts to 2024 for the overall world vaccine market and 5 submarkets – discover the industry's prospects, finding promising places for investments and revenues
–    Assessment of  10 leading companies, and others, discovering their activities and outlooks
–    Market forecasting to 2024 for 11 leading national vaccine contract manufacturing markets – USA, Japan, Germany, France, UK, Spain, Italy, Brazil, Russia, India, China and RoW
–    View opinions from our survey, seeing 4 interviews with leading authorities
–    Investigation of competition and opportunities influencing sales
–    Discussion of what stimulates and restrains the vaccine contract manufacturing market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunities. See how our report could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the vaccines market and vaccine contract manufacturing market. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

To view sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024


Download sample pages

Complete the form below to download your free sample pages for Vaccine Manufacturing Technology and Services: World Market Forecast 2014-2024


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories